Contact

Start a Conversation

We are actively engaging with pharmaceutical companies and investors. Fill out the form below, or reach out directly.

Or email directly: anders@elenaetx.com

What We Offer Partners

  • Ranked synthesis-ready ASO candidate sets
  • Model-informed potency, selectivity, and tolerability assessments
  • Tissue-access strategy matched to the program
  • Target feasibility and steric-blockade druggability review
  • Collaboration structures for target-specific or multi-target campaigns
Anders M. Näär, PhD
Founder & CEO
Elenae Therapeutics
Bakar BioEnginuity Hub
2630 Bancroft Way
Berkeley, CA 94704
Bakar BioEnginuity Hub, UC Berkeley
Bakar BioEnginuity Hub, UC Berkeley